title: CE: A Review of Common Oral Treatments for Breast Cancer: Improving Patient Safety in Nononcology Settings.
abstract: : Breast cancer patients are living longer with the disease than ever before. According to the National Cancer Institute, more than 3 million women in the United States are currently living with a breast cancer diagnosis, and many seek care in nononcology settings, whether for treatment, acute symptoms and complaints related to their cancer diagnosis, or unrelated concerns. Yet many nononcology providers are unfamiliar with the various oral agents used to treat breast cancer, and their possible adverse effects and drug interactions. It is imperative that all providers be aware of these agents and know when a patient is currently taking or has taken them. This article provides an overview of the most common oral treatments for breast cancer and discusses common adverse effects and management.
authors.affiliation: Erica Fischer-Cartlidge is a clinical nurse specialist and Mary Buckley is a clinical nurse at Memorial Sloan Kettering Cancer Center (MSKCC) in New York City. Dina DiCenso is pursuing a master's degree in nursing in the College of Nursing at the State University of New York Downstate Medical Center, Brooklyn. Rosalie Villanueva is an ED nurse at New York-Presbyterian Hospital Queens in Flushing. The authors acknowledge Marisol Hernandez, MSKCC senior reference librarian, for her help with the literature review. Contact author: Erica Fischer-Cartlidge, fischere@mskcc.org. The authors and planners have disclosed no potential conflicts of interest, financial or otherwise.
authors.forename: Erica
authors.initials: E
authors.lastname: Fischer-Cartlidge
authors.forename: Dina
authors.initials: D
authors.lastname: DiCenso
authors.forename: Mary
authors.initials: M
authors.lastname: Buckley
authors.forename: Rosalie
authors.initials: R
authors.lastname: Villanueva
mesh_terms: D000284:Administration, Oral; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000145:classification / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D004496:Education, Continuing; D005260:Female; D006801:Humans; D061214:Patient Safety; D014481:United States
chemical_list: D000970:Antineoplastic Agents